Brixadi Interactions
There are 684 drugs known to interact with Brixadi (buprenorphine), along with 12 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 206 are major, 474 are moderate, and 4 are minor.
- View all 684 medications that may interact with Brixadi
- View Brixadi alcohol/food interactions (1)
- View Brixadi disease interactions (12)
Most frequently checked interactions
View interaction reports for Brixadi (buprenorphine) and the medicines listed below.
- amitriptyline
- Arixtra (fondaparinux)
- Atarax (hydroxyzine)
- azithromycin
- Azithromycin Dose Pack (azithromycin)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- benzonatate
- buspirone
- chloroquine
- clozapine
- Detrol (tolterodine)
- docusate
- doxycycline
- Elavil (amitriptyline)
- Eliquis (apixaban)
- Entresto (sacubitril / valsartan)
- Flomax (tamsulosin)
- gemfibrozil
- Hibiclens (chlorhexidine topical)
- hydrocortisone
- hydroxychloroquine
- hydroxyzine
- imiquimod topical
- Imitrex (sumatriptan)
- indomethacin
- Ingrezza (valbenazine)
- ivermectin
- Keflex (cephalexin)
- Kenalog (triamcinolone topical)
Brixadi alcohol/food interactions
There is 1 alcohol/food interaction with Brixadi (buprenorphine).
Brixadi disease interactions
There are 12 disease interactions with Brixadi (buprenorphine) which include:
- drug dependence
- respiratory depression
- gastrointestinal obstruction
- intracranial pressure
- adrenal insufficiency
- hypotension
- liver disease
- QT prolongation
- renal dysfunction
- urinary retention
- seizure disorders
- biliary tract disease
More about Brixadi (buprenorphine)
- Brixadi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.